Skip to Main

Pete Lawyer is a core member of Boston Consulting Group’s Health Care and Corporate Finance & Strategy practices. He works with clients on innovation, growth, operational excellence, competitive strategy issues, and M&A. Pete is the founder of BCG’s medtech sector and opened the firm’s Minneapolis office in 2007. 

Since joining BCG in 1989, Pete has worked in the firm's Chicago and Tokyo offices as well as Minneapolis. He works principally on core competitive strategy and growth topics, relying on internal innovation and restructuring as well as M&A to help BCG's global clients achieve their goals. 

Before joining BCG, Pete was a reporter for the Wall Street Journal Europe and a commercial banker for First Bank System (now US Bank).

AREAS OF EXPERTISE

EDUCATION

  • MBA, Kellogg School of Management
  • BS, economics, cum laude, St. John’s University

HONORS AND AWARDS

  • F. C. Austin Scholar, Northwestern University

Publications and Videos

" "

Medtech Companies Must Move Faster on Generative AI

To realize the promise and potential for GenAI, medtech executives must make swift and targeted efforts.
For-Cutting-Edge-Innovations-rectangle.jpg

For Cutting-Edge Innovations, the US Pulls Ahead of the EU in Medtech Regulation

A sea change is underway in how companies win regulatory approval for new health care products—particularly in the use of digital technology—and which markets they prioritize.
Monitoring Patient Health from Hospital to Home - rectangle

Monitoring Patient Health from Hospital to Home

When patients move through hospital units—and eventually are discharged—their vital information doesn’t follow. But smarter solutions can track patient data across settings.
Keep-Calm-and-Carry-On-Funding-Medtech-R&D-rectangle.jpg

Keep Calm and Carry On Funding Medtech R&D

Industry leaders set themselves apart with five key practices.
contact-tracing-promise-perils-rectangle-tcm9-250608.jpg

The Promise and the Perils of Contact Tracing

As countries begin to lift restrictions on social interaction, effective deployment of contact tracing will be a critical weapon in the battle to contain COVID-19. But it won’t succeed without privacy safeguards and the right incentives for adoption.
saving-lives-with-data-and-analytics-in-health-care-2880x1620px-tcm9-229248.jpg

Saving Lives with Data and Analytics in Health Care

A recent analysis shows disturbing variations in the use of a key diagnostic for lung cancer patients. Adopting new protocols and tools can lead to better care.
payer-consolidation-1694x950-tcm9-61692.jpg

The Promise of Payer Consolidation for US Health Care

Consolidation won’t move the needle on health care value unless the newly combined insurers use some of the savings to invest in and extend their clinical capabilities.
supercharge-your-services-web-1694x950-tcm9-73488.jpg

Supercharge Your Services

Many product manufacturers find it difficult to add even basic services, let alone sophisticated offerings that deliver value. Insights distilled from service pros show how to profitably tackle the challenge.
competing-on-outcomes-1694x950-tcm9-60077.jpg

Competing on Outcomes: Winning Strategies for Value-Based Health Care

A new focus on value is fundamentally changing the terms of competition in the health care market. The winners will be organizations that compete on outcomes.
health-reform-outcomes-web-new-246x180-tcm9-100488.jpg

Health Reform Should Focus on Outcomes, Not Costs

Targeting better health outcomes is the key to sustainable health reform—both to improve the quality of care and to curb excess health-care spending.
progress-toward-value-based-hc-1694x950-tcm9-105316.jpg

Progress Toward Value-Based Health Care

Which countries are positioned best to adopt value-based health care? BCG assessed the health systems of 12 developed-world countries to find out.
what-value-based-hc-1694x950-tcm9-106511.jpg

What Value-Based Health Care Means for Pharma

Value-based health care represents a major challenge to the pharmaceutical sector. Here’s how pharma companies can turn a potential threat into a promising opportunity.